Real impact and reasons for anti-VEGF treatment delay during Covid-19 pandemic lockdown in neovascular age-related macular degeneration: A national study

被引：0
|
作者：
Zarranz-Ventura, Javier [1 ,2 ]
Pinazo, Roberto Gallego [3 ]
Martin-Pinardel, Ruben [2 ]
Gomez, Laia [4 ]
Escobar, Jose Juan [5 ]
机构：
[1] Hosp Clin Barcelona, Barcelona, Catalunya, Spain
[2] Inst Invest Biomed August Pi & Sunyer, Barcelona, Catalunya, Spain
[3] Clin Oftalvist, Valencia, Valencia, Spain
[4] Novartis Pharmaceut, Barcelona, Spain
[5] Hosp Maig, Barcelona, Catalunya, Spain
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2022年 / 63卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
341
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Anti-VEGF Compounds in the Treatment of Neovascular Age Related Macular Degeneration
    Campa, C.
    Harding, S. P.
    CURRENT DRUG TARGETS, 2011, 12 (02) : 173 - 181
  • [22] VEGF levels in serum and the outcome of intravitreal anti-VEGF treatment in neovascular age-related macular degeneration
    Abedi, Farshad
    Wickremasinghe, Sanjeewa
    Islam, Amirul
    Guymer, Robyn H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [23] Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration: Therapeutic Strategies
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2012, 229 (05) : 541 - 547
  • [24] Bevacizumab (Avastin) conjugated microbubbles for anti-VEGF treatment of neovascular age-related macular degeneration
    Zhang, Leilei
    Xu, Jeff
    Huang, Jiwei
    Roberts, Cynthia
    Xu, Ronald
    OPHTHALMIC TECHNOLOGIES XX, 2010, 7550
  • [25] Genetic Association Analysis of Anti-VEGF Treatment Response in Neovascular Age-Related Macular Degeneration
    Strunz, Tobias
    Poellmann, Michael
    Gamulescu, Maria-Andreea
    Tamm, Svenja
    Weber, Bernhard H. F.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (11)
  • [26] Anti-VEGF therapies for the treatment of age-related macular degeneration
    Gower, Emily W.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2012, 1 (06) : 485 - 488
  • [27] SMOKING STATUS AND THE EFFECT ON ANTI-VEGF TREATMENT OUTCOMES IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Vittorio, Alexander
    Vuong Nguyen
    Barthelmes, Daniel
    Arnold, Jennifer
    Cheung, Gemmy
    Murray, Neil
    Gillies, Mark
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 46 : 126 - 126
  • [28] Brolucizumab: A Newly Developed Anti-VEGF Molecule for the Treatment of Neovascular Age-Related Macular Degeneration
    Tadayoni, Ramin
    Sararols, Laura
    Weissgerber, Georges
    Verma, Rohini
    Clemens, Andreas
    Holz, Frank G.
    OPHTHALMOLOGICA, 2021, 244 (02) : 93 - 101
  • [29] Development of Subretinal Fibrosis After Anti-VEGF Treatment in Neovascular Age-Related Macular Degeneration
    Hwang, John C.
    Del Priore, Lucian V.
    Freund, K. Bailey
    Chang, Stanley
    Iranmanesh, Reza
    OPHTHALMIC SURGERY LASERS & IMAGING, 2011, 42 (01) : 6 - 11
  • [30] Characterizing anti-VEGF treatment patterns for neovascular age-related macular degeneration in the United Kingdom
    Jain, Mishank
    Cantrell, Ronald
    Chidambaram, Jaya Devi
    Judge, Davneet
    Dodds, Melanie
    McGrory, Sarah
    Bailey, Clare
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
12345